Literature DB >> 34178776

Antimicrobial Susceptibility, Serotyping, and Molecular Characterization of Antibiotic Resistance Genes in Listeria monocytogenes Isolated from Pregnant Women with a History of Abortion.

Siamak Heidarzadeh1,2, Mohammad Reza Pourmand1, Saeedeh Hasanvand3, Reyhaneh Pirjani4, Davoud Afshar2, Matina Noori4, Mohammad Mehdi Soltan Dallal1,5.   

Abstract

BACKGROUND: Listeria monocytogenes show high mortality among pregnant women and newborns. This study aimed to detect L. monocytogenes in pregnant women with a history of abortion and assess the serotypes, antibiotic susceptibility patterns, and its resistance genes.
METHODS: Overall, 400 vaginal swabs were taken from pregnant women with a history of abortion in the past few years in a tertiary care hospital in Tehran, Iran, during 2015-2018. Antibiotics susceptibility to a panel of 10 antibiotics was determined using the standard disk diffusion method and the isolates serotyped by the agglutination method. The antimicrobial-resistant isolates were also screened for the presence of tetM, ermB and dfrD genes by PCR.
RESULTS: Overall, 22 L. monocytogenes isolates were identified. High rates of resistance were observed for trimethoprim (50%; n=11), sulphamethoxazole (50%; n=11), tetracycline (45.45%; n=10) and gentamicin (36.36%; n=8). From 22 L. monocytogenes isolates, 13 (59.10 %), 5 (22.73%), 3 (13.63%) and 1 (4.54%) belonged to serotypes 4b, 1/2a, 1/2b, and 3c, respectively. The genetic determinant tetM was detected in 70% of the tetracycline-resistant isolates. Out of 11 trimethoprim-resistant isolates, 27.27% isolates contained dfrD. Moreover, the ermB gene was found in 83.33% of the erythromycin-resistant isolates.
CONCLUSION: Ampicillin and partly penicillin consider to be suitable antimicrobial agents to treat human listeriosis. Moreover, due to resistance against many antibiotics, it is necessary to continue monitoring and managing antimicrobial resistance.
Copyright © 2021 Heidarzadeh et al. Published by Tehran University of Medical Sciences.

Entities:  

Keywords:  Genes; Listeria monocytogenes; Pregnant women

Year:  2021        PMID: 34178776      PMCID: PMC8213617          DOI: 10.18502/ijph.v50i1.5084

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Listeria monocytogenes is an important pathogen in pregnant women, neonates, elderly and immunocompromised individuals and its disease is usually an asymptomatic or mild illness for healthy adults (1, 2). However, the elderly and immunosuppressive individuals may experience a severe disease such as pneumonia, meningitis and meningoencephalitis (3). L. monocytogenes causes the highest abortion rates in newborns (20%–30%) in comparison with other bacteria such as vaginosis bacteria (Mobiluncus and Gardnerella) (4). More than 30% of pregnancy-associated listeriosis cases result in miscarriage, premature labor, stillbirth, spontaneous abortion or neonatal death (3, 5). The history of prior abortion increases the risk of Listeria infection in pregnant women. Women with a history of abortion are susceptible to listeriosis more than those without a history of abortion (6, 7). According to the severe morbidity and high mortality rate of listeriosis in newborns, it is essential to ensure the efficiency of antibiotics against L. monocytogenes and monitor the emergence of resistant strains (8). Drug resistance in L. monocytogenes is rarely seen (9). However, some surveys have recently described an increased rate of resistance to one or multiple common antibiotics in some strains isolated from clinical and environmental sources (9, 10). Resistance to antibiotics in L. monocytogenes results from the acquisition of genes carried by transferable plasmids and conjugative transposons (11). Moreover, some efflux pumps have also been identified in L. monocytogenes (12). Recently, the incidence of antimicrobial-resistant strains has been increasing (13). The misuse and inappropriate consumption of antibiotics result in the appearance of antibiotic resistance, especially multidrug-resistant (MDR) strains (14). Hence, the identification of L. monocytogenes prevalence and its antibiotic resistance seems to be essential (14). In 1988, the first clinical MDR strain of L. monocytogenes has been detected with resistance to tetracycline, streptomycin, erythromycin and chloramphenicol (15). After that, different drug resistance patterns to one or several antibiotics in environmental, food and clinical cases have also been identified (16). Generally, the emergence of MDR strains of L. monocytogenes is a growing problem in public health. There are limited data about Listeria prevalence in Iran and most cases, the bacterium is not detected or misdiagnosed, which can lead to abortion and severe complications. The objective of present study was to detect L. monocytogenes in pregnant women with a history of abortion. Moreover, the isolated strains were also surveyed for their serotypes, antibiotic susceptibility patterns, and resistance potential genes.

Materials and Methods

Specimens and Bacterial isolates

In this cross-sectional study, 400 vaginal swabs were taken from pregnant women with a history of abortion in the past few years in a tertiary care hospital in Tehran, Iran from 2015 to 2017. The inclusion criteria included pregnant women with a history of abortion admitted to a tertiary care hospital in Tehran, Iran. Pregnant women without the history of abortion, healthy pregnant women, and women with other cases of bacterial vaginosis and chronic diseases were excluded from the study. All specimens were cultured into polymyxinacriflavine-lithium chloride-ceftazidime-esculinmannitol (PALCAM, Merck, Germany), Oxford agar (Difco, USA) (17) and selective CHROMagar (CHROMAgar, Paris, France) media (18) and Listeria monocytogenes suspected isolates were tested using standard biochemical tests (such as catalase, oxidase, motility, sugar fermentation tests with rhamnose, xylose, mannitol, α-methyl D-mannopyranoside, motility, hemolysis and CAMP tests) (17) and then confirmed by polymerase chain reaction (PCR) method (19). The isolated bacteria were stored at −80 °C in cryovials (MAST Diagnostics, Merseyside, UK).

Serotyping

All isolates were serotyped by the commercially prepared Listeria antisera against somatic (O) and flagellar (H) antigens according to the manufacturer’s instructions (Denka-Seiken Co. Ltd., Tokyo, Japan) (20).

Antibiotic susceptibility

Twenty-two L. monocytogenes strains isolated from clinical samples were examined for antibiotic sensitivity. Four-five colonies of L. monocytogenes isolates were incubated for 24 h at 37 °C in brain heart infusion broth (BHI, Merck, Germany), and then transferred to Mueller Hinton Agar with 5% Sheep Blood (Merck, Germany). The plates were incubated at 37 °C for 24 hours. The antimicrobial susceptibility testing for these isolates was conducted using a procedure by Kirby-Bauer method, according to Clinical & Laboratory Standards Institute (CLSI 2016) disk diffusion assay, with commonly used antibiotics in the hospital: penicillin G (P/10 U), ampicillin (AMP/10 μg), trimethoprim (TS/5 μg), sulfamethoxazole (ER/25 μg), tetracycline (TE/30 μg), chloramphenicol (C/30 μg), ciprofloxacin (CIP/5 μg), erythromycin (E/15 μg), gentamicin (CN/10 μg), and streptomycin (S/25 μg) (MAST, UK) (21, 22). The reference strains of L. monocytogenes ATCC® 19115TM and Staphylococcus aureus subsp. aureus ATCC® 25923TM (prepared from Pasteur Institute of Iran) were used for quality control for zone diameter determination.

Molecular analysis

All isolates were screened for the tetM, ermB, and drfD genes using the primers previously described (Table 1) (9).
Table 1:

Identities and nucleotide sequences of L. monocytogenes resistance gene primers

PCR testPrimer nameSequence (5′→3′)Target geneSize of ampliconRef
PCR1dfrD-F5′-AGAGTAATCGGCAAGGATAACG-3′dfrD199 bp[6]
dfrD-R5′-AATGGGCAATTTCACAATCC-3′
PCR2ermB-F5′-GAAAAGGTACTCAACCAAATA-3′ermB636 bp[6]
ermB-R5′ AGTAACGGTACTTAAATTGTTTAC-3′
PCR3tetM-F5′-GTGGACAAAGGTACAACGAG-3′tetM405 bp[6]
tetM-R5′-CGGTAAAGTTCGTCACACAC-3′

F: Forward

R: Reverse bp: base pair(s)

Identities and nucleotide sequences of L. monocytogenes resistance gene primers F: Forward R: Reverse bp: base pair(s) DNA extraction from bacterial isolates was performed using the Qiagen RNA/DNA Kit (Qiagen, USA) in accordance to the manufacturer’s instruments and the extracted DNA was stored at −20 °C. The PCR reaction mixture (25 μL) included 50 ng of DNA, 2.5 μL of 10X PCR buffer, 1μL MgCl2, 1-μL of dNTPs, 1 μL of each primer (50 pmol/mL) and 1 U of Taq DNA polymerase (Thermo Fisher Scientific). PCR amplification started with an initial denaturation step at 94 °C for 5 min, followed by 35 cycles (denaturation at 95 °C for 30 sec, annealing at primer-specific temperature for 30 sec, and extension at 72 °C for 30 sec) and a final extension for 10 min at 72 °C. All amplicons were electrophoresed into aga-rose gel (1% agarose in 0.5 X TBE buffer), stained with ethidium bromide and visualized under a UV light transilluminator.

Ethical approval

The study was approved by the Ethics Committee of Tehran University of Medical Sciences, with number of IR.TUMS.SPH.REC.1395.1485.

Results

Out of 400 clinical specimens, 22 samples were found to be positive for L. monocytogenes. Ciprofloxacin showed the highest sensitivity reaching 81.82% (n=18) of the tested isolates. However, high rates of resistance were observed for trimethoprim, sulphamethoxazole, tetracycline, and gentamicin, while low rate of resistance was remarked to ciprofloxacin, ampicillin and penicillin G (Table 2).
Table 2:

Antimicrobial resistance profiles of L. monocytogenes isolated from clinical samples in Iran

VariableDose (μg/disc)Sensitivity of the isolates (%)

RIS
Ampicillin10 μg010 (45.45%)12 (54.55%)
Gentamicin10 μg8 (36.36%)014 (63.64%)
Penicillin G10 U010 (45.45%)12 (54.55%)
Trimethoprim5 μg11 (50%)7 (31.81%)4 (18.18%)
Tetracycline30 μg10 (45.45%)012 (54.55%)
Ciprofloxacin5 μg4 (18.18%)018 (81.82%)
Sulfamethoxazole25 μg11 (50%)7 (31.82%)4 (18.18%)
Erythromycin15 μg6 (27.27%)4 (18.18%)12 (54.55%)
Streptomycin10 μg6 (27.27%)4 (18.18%)12 (54.55%)
Chloramphenicol30 μg6 (27.27%)6 (27.27%)10 (45.45%)

R: resistant, I: intermediate, S: susceptible.

Antimicrobial resistance profiles of L. monocytogenes isolated from clinical samples in Iran R: resistant, I: intermediate, S: susceptible. Intermediate resistance to ampicillin 10/22 (45.45%), penicillin G 10/22 (45.45%), trimethoprim 7/22 (36.36%), sulfamethoxazole 7/22 (36.36%), erythromycin 4/22 (18.18%), streptomycin 4/22 (18.18%) and chloramphenicol 6/22 (27.27%) was exhibited by some of the isolates. However intermediate resistance to tetracycline, gentamicin, and ciprofloxacin was not observed in any of the isolated strains. The susceptibility profile of erythromycin and streptomycin was the same with 6 (27.27%) of the isolate been resistant while 4 (18.18%) and 12 (54.55%) were intermediately resistant and sensitive, respectively. Of the 22 isolates, 4 (18.18%) were resistant to only one class of antibiotic, while 18 (81.82%) were resistant to two or more classes antibiotics; none of the isolated strains of L. monocytogenes was susceptible to the entire antibiotics tested. All 22 isolates obtained from clinical samples were serotyped. The predominant serotypes were 4b (13, 59.10%), followed by 1/2a (5, 22.73%), 1/2b (3, 13.63%), and 3c (1, 4.54%). Twenty-two isolates of L. monocytogenes from clinical samples were screened for the presence of tetM, ermB and drfD genes (Table 3, Figs. 1–3). The genetic determinant tetM was detected in 7 (70%) of the tetracycline-resistant isolates. Out of 11 trimethoprim-resistant isolates, three isolates (27.27%) contained dfrD. Moreover, the ermB gene was found in 5 (83.33%) of the erythromycin-resistant isolates. Two strains harbored both tetM and ermB genes simultaneously, while both tetM and drfD genes were identified only in one strain. As well, one strain carried tetM, ermB, and drfD simultaneously, and twelve had none of the genes.
Table 3:

Detection of L. monocytogenes isolates and resistance profiles used in this study

IsolateSpeciesSerotypetetMermBdrfD
Lm1L. monocytogenes4b
Lm2L. monocytogenes1/2b
Lm3L. monocytogenes4b +
Lm4L. monocytogenes4b + + +
Lm5L. monocytogenes4b +
Lm6L. monocytogenes3c
Lm7L. monocytogenes4b
Lm8L. monocytogenes4b + +
Lm9L. monocytogenes1/2a
Lm10L. monocytogenes1/2a
Lm11L. monocytogenes1/2b +
Lm12L. monocytogenes4b +
Lm13L. monocytogenes1/2a
Lm14L. monocytogenes4b
Lm15L. monocytogenes4b +
Lm16L. monocytogenes4b + +
Lm17L. monocytogenes4b
Lm18L. monocytogenes1/2a + +
Lm19L. monocytogenes1/2b
Lm20L. monocytogenes1/2a
Lm21L. monocytogenes4b
Lm22L. monocytogenes4b +

Positive/Existence of the gene;

Negative/Absence of the gene

Fig. 1:

Polymerase chain reaction (PCR) analyses of ermB gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 636-bp fragment of the ermB gene. Lane 1= DNA ladder 100 bp, Lane 2= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 3= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 4, 5, 6 and 7= positive results

Fig. 3:

Polymerase chain reaction (PCR) analyses of dfrD gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 199-bp fragment of the dfrD gene. Lane 1= DNA ladder 100 bp, Lane 2= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 3= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 4, 5, and 6= positive results

Polymerase chain reaction (PCR) analyses of ermB gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 636-bp fragment of the ermB gene. Lane 1= DNA ladder 100 bp, Lane 2= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 3= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 4, 5, 6 and 7= positive results Polymerase chain reaction (PCR) analyses of tetM gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 405-bp fragment of the tetM gene. Lane 1= DNA ladder 100 bp, Lane 2= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 3= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 4, 5, and 6= positive results Polymerase chain reaction (PCR) analyses of dfrD gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 199-bp fragment of the dfrD gene. Lane 1= DNA ladder 100 bp, Lane 2= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 3= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 4, 5, and 6= positive results Detection of L. monocytogenes isolates and resistance profiles used in this study Positive/Existence of the gene; Negative/Absence of the gene All patients with listeriosis were reported to specialist. Antibiogram results were also reported to the specialist for appropriate treatment. Furthermore, all patients were followed up for disease progression and recovery. Postpartum follow-up was also performed on all pregnant women with listeriosis. Pregnant women with Listeria infection were treated with intravenous ampicillin for 14 d, 2 g every 4 h, and gentamicin, 100 mg every 8 h, followed by ampicillin alone for 14 days. Erythromycin has been used as an alternative to penicillin and gentamicin for the treatment of resistant isolates.

Discussion

In the present study, the prevalence of L. monocytogenes in pregnant women was 5.5% (22 positives from 400 samples) which is comparable with other studies in Iran. The prevalence of L. monocytogenes with human origin was 10% and most of isolates have belonged to 4b, 1/2a, and 1/2b serotypes (23). Similarly, in our study, the predominant serotypes were 4b, 1/2a, 1/2b and 3c. Antibiotic resistance and inappropriate empirical therapy of listeriosis can lead to increased mortality in patients (24). Although L. monocytogenes was distinguished to be susceptible to a wide range of antibiotics during the past two decades, the rate of antimicrobial resistance in L. monocytogenes is increasing (13). In Iran, resistance of L. monocytogenes to tetracycline, penicillin G, streptomycin, sulfamethoxazole, gentamicin, erythromycin, and ciprofloxacin has been described (25, 26). MDR L. monocytogenes was isolated from veterinary, food, environmental, and clinical samples (27–29). Most of the isolates were resistant to tetracycline, trimethoprim, and sulfamethoxazole, while were sensitive to penicillin G and ampicillin. However, in contrast to our study, most of the strains were sensitive to trimethoprim, sulfamethoxazole, and tetracycline, but were resistant to ampicillin, cefotaxime, and penicillin (30). All isolates were reported to be sensitive to commonly used antibiotics (31). Similar to our study, high resistance to streptomycin and susceptibility to penicillin G and ampicillin were reported (32, 33). In this study, some L. monocytogenes isolates were resistant to the most commonly used antibiotics for treating Listeria infections including ampicillin, penicillin G, trimethoprim, sulfamethoxazole, erythromycin, streptomycin and chloramphenicol, and these results concur with those found in ducks isolates (34). Conversely, no incidence of resistance to ampicillin, amoxicillin/clavulanate, cefotaxime, meropenem, sulfamethoxazole/trimethoprim, tetracycline, erythromycin, streptomycin, and gentamicin was detected (24). Penicillin or ampicillin in combination with an aminoglycoside such as gentamicin is considered to be choice therapy for listeriosis (35). However, Co-trimoxazole (trimethoprim/sulfamethoxazole) appears to be a reasonable alternative to ampicillin for the treatment of Listeria infection in patients who are allergic to or intolerant of this antibiotic (29, 35). The genetic determinant dfrD was detected in 27.27% of the trimethoprim-resistant isolates. The first clinical strain of L. monocytogenes with high-level resistance to trimethoprim was identified in 1995 in France and carried the dfrD gene (36). The dfrD gene encodes dihydrofolate reductase (DHFR) which is a key enzyme in the tetrahydrofolate pathway, in which it reduces dihydrofolic acid (DHF) to tetrahydrofolic acid (FH4) (37). The commonest mechanism of acquired resistance to trimethoprim (TMP) is a plasmid-mediated production of an insusceptible form of DHFR (37). In recent years, the increase in the rate of resistance to erythromycin in L. monocytogenes is of clinical concern, since erythromycin has been effective for treating pregnant women with listeriosis (38). Among the several mechanisms of erythromycin resistance found in Listeria, the most commonly found in strains are methylation of 23S rRNA by erm genes (erythromycin ribosome methylase), and drug efflux pumps mediated by the mef(A) or msr(A) genes (37). In our study, the ermB gene was found in 83.33% of the erythromycin-resistant isolates. Some antimicrobial resistance genes were assessed and detected no ermB gene in any of the L. monocytogenes isolates (13). Instead, ermA and ermC resistance genes were determined in Listeria species respectively (39, 40). Two types of resistance mechanisms to tetracyclines have been observed in Listeria spp.: tetracycline efflux which confers resistance to tetracycline [tet(L)] and ribosomal protection which confers resistance to both tetracycline/minocycline [tet(M) and tet(S)] (37). We found the tetM in 70% of the tetracycline-resistant isolates. The prevalence rate of the tetM gene in our study is in accordance with previous studies, in which a high rate of these resistance genes in L. monocytogenes isolates was described (13, 29, 41). Two isolates carried tetM and ermB genes and antimicrobial multi-resistance profiles were found in 10% of isolates (38). Similar to other previous studies, the current study indicates that the presence of antibiotic resistance genes in Listeria isolates did not always associate with phenotypic antimicrobial resistance. Hence, other mechanisms such as reduced permeability, efflux pump activation, mutations, or genes encoding enzymes with antibacterial activities may have attributed to the antibiotic resistance phenotypes (13, 38). Nugent’s criteria are frequently used to identify bacteria via Gram stain of vaginal swabs. The Nugent Score has been used to evaluate 3 types of bacteria via Gram stain including Lactobacillus morphotypes, Gardnerella vaginalis morphotypes and Mobiluncus spp. morphotypes, and do not apply to Listeria (42). Therefore, we did not use this method. In this study, the predominant clinical isolates were serotype 4b (59.10%), related to a higher mortality rate in patients infected, especially in infants. These results concur with prior studies. About 60% of the clinical isolates in Brazil were serotype 4b and 19% were serotype 1/2b (43). Serotype 4b was most commonly isolated from clinical samples (44, 45). The recovery of twenty-two L. monocytogenes isolates from cases of pregnant women’s vaginal swabs indicates a serious threat to neonates. Most isolates of L. monocytogenes had resistance to one or more antibiotics. Although L. monocytogenes was distinguished to be nearly susceptible to a wide spectrum of antibiotics in the past few decades, several more recent surveys (13) and results of the present study indicate that the rate of resistance to the different antibiotic in L. monocytogenes is growing. Some challenges were encountered during carrying out some of the purposes of the current study, especially in the course of sampling from some people. A limitation of our study was the fact that sexual practices are part of the individual’s private life. Not all of the women in this study felt convenient answering honestly and morally, even when guaranteed secrecy. Matched controls were not included in the study to draw out a conclusion.

Conclusion

Ampicillin and partly penicillin consider being suitable antimicrobial agents to treat human listeriosis. Although the resistance to antibiotics commonly used in human listeriosis treatment is an important public health concern, therefore we recommend regular surveillance of L. monocytogenes infections, monitoring antimicrobial susceptibility patterns and rational use of appropriate medications for the treatment of patients.

Ethical considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  34 in total

1.  [Listeria monocytogenes in women of reproductive age].

Authors:  Mufida Aljicević; Edina Beslagić; Sukrija Zvizdić; Sadeta Hamzić; Sabina Mahmutović
Journal:  Med Arh       Date:  2005

2.  Molecular Serogrouping of Listeria monocytogenes from Brazil Using PCR.

Authors:  Anderson Carlos Camargo; Deyse Christina Vallim; Ernesto Hofer; Luís Augusto Nero
Journal:  J Food Prot       Date:  2016-01       Impact factor: 2.077

3.  Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes.

Authors:  Sylvain Godreuil; Marc Galimand; Guy Gerbaud; Christine Jacquet; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Seropositivity for Listeria monocytogenes in women with spontaneous abortion: a case-control study in Iran.

Authors:  Mahin Jamshidi; Abdolreza Sotoodeh Jahromi; Parivash Davoodian; Malihe Amirian; Mehrangiz Zangeneh; Fatemeh Jadcareh
Journal:  Taiwan J Obstet Gynecol       Date:  2009-03       Impact factor: 1.705

5.  Incidence of antibiotic resistance in Listeria species.

Authors:  E Charpentier; G Gerbaud; C Jacquet; J Rocourt; P Courvalin
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

6.  Development of a novel selective and differential medium for the isolation of Listeria monocytogenes.

Authors:  Sang-Hyun Park; Pahn-Shick Chang; Sangryeol Ryu; Dong-Hyun Kang
Journal:  Appl Environ Microbiol       Date:  2013-11-22       Impact factor: 4.792

Review 7.  Listeria Placental Infection.

Authors:  José A Vázquez-Boland; Emilia Krypotou; Mariela Scortti
Journal:  MBio       Date:  2017-06-27       Impact factor: 7.867

Review 8.  Epidemiology of Listeria monocytogenes prevalence in foods, animals and human origin from Iran: a systematic review and meta-analysis.

Authors:  Reza Ranjbar; Mehrdad Halaji
Journal:  BMC Public Health       Date:  2018-08-23       Impact factor: 3.295

9.  Listeriosis outbreaks and associated food vehicles, United States, 1998-2008.

Authors:  Emily J Cartwright; Kelly A Jackson; Shacara D Johnson; Lewis M Graves; Benjamin J Silk; Barbara E Mahon
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

Review 10.  Listeriosis during Pregnancy: A Public Health Concern.

Authors:  Teresa Mateus; Joana Silva; Rui L Maia; Paula Teixeira
Journal:  ISRN Obstet Gynecol       Date:  2013-09-26
View more
  2 in total

Review 1.  Antibiotic Resistance in Bacteria-A Review.

Authors:  Renata Urban-Chmiel; Agnieszka Marek; Dagmara Stępień-Pyśniak; Kinga Wieczorek; Marta Dec; Anna Nowaczek; Jacek Osek
Journal:  Antibiotics (Basel)       Date:  2022-08-09

2.  Evidence of Virulent Multi-Drug Resistant and Biofilm-Forming Listeria Species Isolated from Various Sources in South Africa.

Authors:  Christ-Donald Kaptchouang Tchatchouang; Justine Fri; Peter Kotsoana Montso; Giulia Amagliani; Giuditta Fiorella Schiavano; Madira Coutlyne Manganyi; Giulia Baldelli; Giorgio Brandi; Collins Njie Ateba
Journal:  Pathogens       Date:  2022-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.